Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FT2GT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,437
Award facts
- Contract value 100% obligated
- $24,436.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gemtesa 75 mg tablets (90-count packages) valued at $24,436.57. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and runs through December 2026.
The contract supports the Defense Health Agency's pharmaceutical supply requirements through a comprehensive vehicle that enables AmerisourceBergen Drug Corp to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military and federal healthcare systems worldwide. Gemtesa (mirabegron), a medication used in the treatment of overactive bladder, exemplifies the neurological and specialty pharmaceutical products the company supplies under this strategic partnership. As a leading federal medical vendor, AmerisourceBergen Drug Corp maintains capability to meet competitive procurement requirements and serves as a critical component of the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FT2GT?
SPE2DR26FT2GT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FT2GT worth?
The government has obligated $24,437 on SPE2DR26FT2GT.
Is contract SPE2DR26FT2GT an order under another contract?
Yes. SPE2DR26FT2GT is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2GT competed?
The extent of competition for SPE2DR26FT2GT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award